Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Alex Roher
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Living Beings
Procedures
Genes & Molecular Sequences
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
31
Kuo, Yu-Min
29
Kokjohn, Tyler
28
Beach, Thomas
19
Emmerling, Mark
18
Esh, Chera
17
Kalback, Walter
16
Luehrs, Dean
14
Sue, Lucia
13
Ball, Melvyn
10
Stern, David
10
Castaño, Eduardo
10
Walker, Douglas G.
8
Cotter, Robert
8
Yan, Shi Du
7
Schmidt, Ann Marie
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Alex Roher (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Roher Alex E; Maarouf Chera L; Sue Lucia I; Hu Yiran; Wilson Jeffrey; Beach Thomas G
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2009;14(7):493-501.
-
2009: Kokjohn Tyler A; Roher Alex E
Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(4):340-7.
-
2009: Kokjohn Tyler A; Roher Alex E
Antibody responses, amyloid-beta peptide remnants and clinical effects of AN-1792 immunization in patients with AD in an interrupted trial.
CNS & neurological disorders drug targets 2009;8(2):88-97.
-
2009: Roher Alex E; Esh Chera L; Kokjohn Tyler A; Castaño Eduardo M; Van Vickle Gregory D; Kalback Walter M; Patton R Lyle; Luehrs Dean C; Daugs Ian D; Kuo Yu-Min; Emmerling Mark R; Soares Holly; Quinn Joseph F; Kaye Jeffrey; Connor Donald J; Silverberg Nina B; Adler Charles H; Seward James D; Beach Thomas G; Sabbagh Marwan N
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(1):18-29.
-
2008: Beach Thomas G; Sue Lucia I; Walker Douglas G; Roher Alex E; Lue LihFen; Vedders Linda; Connor Donald J; Sabbagh Marwan N; Rogers Joseph
The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.
Cell and tissue banking 2008;9(3):229-45.
-
2008: Van Vickle Gregory D; Esh Chera L; Daugs Ian D; Kokjohn Tyler A; Kalback Walter M; Patton R Lyle; Luehrs Dean C; Walker Douglas G; Lue Lih-Fen; Beach Thomas G; Davis Judianne; Van Nostrand William E; Castaño Eduardo M; Roher Alex E
Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
The American journal of pathology 2008;173(2):483-93.
-
2008: Llovera Ramiro E; de Tullio Matías; Alonso Leonardo G; Leissring Malcolm A; Kaufman Sergio B; Roher Alex E; de Prat Gay Gonzalo; Morelli Laura; Castaño Eduardo M
The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
The Journal of biological chemistry 2008;283(25):17039-48.
-
2008: Van Vickle Gregory D; Esh Chera L; Kokjohn Tyler A; Patton R Lyle; Kalback Walter M; Luehrs Dean C; Beach Thomas G; Newel Amanda J; Lopera Francisco; Ghetti Bernardino; Vidal Ruben; Castaño Eduardo M; Roher Alex E
Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease.
Molecular medicine (Cambridge, Mass.) 2008;14(3-4):184-94.
-
2008: Maarouf Chera L; Daugs Ian D; Spina Salvatore; Vidal Ruben; Kokjohn Tyler A; Patton R Lyle; Kalback Walter M; Luehrs Dean C; Walker Douglas G; Castaño Eduardo M; Beach Thomas G; Ghetti Bernardino; Roher Alex E
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations.
Molecular neurodegeneration 2008;3():20.
-
2007: Van Vickle Gregory D; Esh Chera L; Kalback Walter M; Patton R Lyle; Luehrs Dean C; Kokjohn Tyler A; Fifield Frederick G; Fraser Paul E; Westaway David; McLaurin Joanne; Lopez John; Brune Daniel; Newel Amanda J; Poston Marissa; Beach Thomas G; Roher Alex E
TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation.
Biochemistry 2007;46(36):10317-27.
-
2007: Beach Thomas G; Wilson Jeffrey R; Sue Lucia I; Newell Amanda; Poston Marissa; Cisneros Raquel; Pandya Yoga; Esh Chera; Connor Donald J; Sabbagh Marwan; Walker Douglas G; Roher Alex E
Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles.
Acta neuropathologica 2007;113(1):13-21.
-
2006: Dudkin K N; Chueva I V; Makarov F N; Bich T G; Roher A E
Disorders of learning and memory processes in a monkey model of Alzheimer's disease: the role of the associative area of the cerebral cortex.
Neuroscience and behavioral physiology 2006;36(8):789-99.
-
2006: Roher Alex E; Garami Zsolt; Alexandrov Andrei V; Kokjohn Tyler A; Esh Chera L; Kalback Walter M; Vedders Linda J; Wilson Jeffrey R; Sabbagh Marwan N; Beach Thomas G
Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease.
Neurological research 2006;28(6):672-8.
-
2006: Patton R Lyle; Kalback Walter M; Esh Chera L; Kokjohn Tyler A; Van Vickle Gregory D; Luehrs Dean C; Kuo Yu-Min; Lopez John; Brune Daniel; Ferrer Isidro; Masliah Eliezer; Newel Amanda J; Beach Thomas G; Castaño Eduardo M; Roher Alex E
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
The American journal of pathology 2006;169(3):1048-63.
-
2006: Castaño Eduardo M; Roher Alex E; Esh Chera L; Kokjohn Tyler A; Beach Thomas
Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.
Neurological research 2006;28(2):155-63.
-
2006: Roher Alex E; Kokjohn Tyler A; Beach Thomas G
An association with great implications: vascular pathology and Alzheimer disease.
Alzheimer disease and associated disorders 2006;20(1):73-5.
-
2005: Watson Desiree; Castaño Eduardo; Kokjohn Tyler A; Kuo Yu-Min; Lyubchenko Yuri; Pinsky David; Connolly E Sander; Esh Chera; Luehrs Dean C; Stine W Blaine; Rowse Linda M; Emmerling Mark R; Roher Alex E
Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Neurological research 2005;27(8):869-81.
-
2005: Esh Chera; Patton Lyle; Kalback Walter; Kokjohn Tyler A; Lopez John; Brune Daniel; Newell Amanda J; Beach Thomas; Schenk Dale; Games Dora; Paul Steven; Bales Kelly; Ghetti Bernardino; Castaño Eduardo M; Roher Alex E
Altered APP processing in PDAPP (Val717 --> Phe) transgenic mice yields extended-length Abeta peptides.
Biochemistry 2005;44(42):13807-19.
-
2005: Roher A E; Esh C; Kokjohn T; Sue L; Beach T
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.
Neurology 2005;65(6):974; author reply 974.
-
2005: Dudkin K N; Chueva I V; Makarov F N; Bich T G; Roher A E
[Disorders in learning and memory processes in the monkey model of Alzheimer's disease: the role of the cerebral cortex associative areas]
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova / Rossiiskaia akademiia nauk 2005;91(8):857-71.
-
2005: Miravalle Leticia; Calero Miguel; Takao Masaki; Roher Alex E; Ghetti Bernardino; Vidal Ruben
Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques.
Biochemistry 2005;44(32):10810-21.
-
2005: Chaney Michael O; Stine W Blaine; Kokjohn Tyler A; Kuo Yu-Min; Esh Chera; Rahman Afroza; Luehrs Dean C; Schmidt Ann Marie; Stern David; Yan Shi Du; Roher Alex E
RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.
Biochimica et biophysica acta 2005;1741(1-2):199-205.
-
2004: Roher Alex E; Esh Chera; Rahman Afroza; Kokjohn Tyler A; Beach Thomas G
Atherosclerosis of cerebral arteries in Alzheimer disease.
Stroke; a journal of cerebral circulation 2004;35(11 Suppl 1):2623-7.
-
2004: Arancio Ottavio; Zhang Hui Ping; Chen Xi; Lin Chang; Trinchese Fabrizio; Puzzo Daniela; Liu Shumin; Hegde Ashok; Yan Shi Fang; Stern Alan; Luddy John S; Lue Lih-Fen; Walker Douglas G; Roher Alex; Buttini Manuel; Mucke Lennart; Li Weiying; Schmidt Ann Marie; Kindy Mark; Hyslop Paul A; Stern David M; Du Yan Shirley Shi
RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.
The EMBO journal 2004;23(20):4096-105.
-
2004: Kalback Walter; Esh Chera; Castaño Eduardo M; Rahman Afroza; Kokjohn Tyler; Luehrs Dean C; Sue Lucia; Cisneros Raquel; Gerber Francoise; Richardson Claudia; Bohrmann Bernd; Walker Douglas G; Beach Thomas G; Roher Alex E
Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease.
Neurological research 2004;26(5):525-39.
-
2004: Roher Alex E; Kokjohn Tyler A; Esh Chera; Weiss Nicole; Childress Jennifer; Kalback Walter; Luehrs Dean C; Lopez John; Brune Daniel; Kuo Yu-Min; Farlow Martin; Murrell Jill; Vidal Ruben; Ghetti Bernardino
The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates.
The Journal of biological chemistry 2004;279(7):5829-36.
-
2003: Roher Alex E; Esh Chera; Kokjohn Tyler A; Kalback Walter; Luehrs Dean C; Seward James D; Sue Lucia I; Beach Thomas G
Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(11):2055-62.
-
2003: Chaney Michael O; Baudry Jerome; Esh Chera; Childress Jennifer; Luehrs Dean C; Kokjohn Tyler A; Roher Alex E
A beta, aging, and Alzheimer's disease: a tale, models, and hypotheses.
Neurological research 2003;25(6):581-9.
-
2003: Roher Alex E; Kuo Yu-Min; Esh Chera; Knebel Carmen; Weiss Nicole; Kalback Walter; Luehrs Dean C; Childress Jennifer L; Beach Thomas G; Weller Roy O; Kokjohn Tyler A
Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
Molecular medicine (Cambridge, Mass.) 2003;9(3-4):112-22.
-
2003: Dudkin K N; Chueva I V; Makarov F N; Beach T G; Roher A E
Alterations of the sensory and cognitive components of operative memory in a monkey model of Alzheimer's disease.
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections / translated from Russian 2003;389():99-101.
-
2002: Roher Alex E; Kokjohn Tyler A
Of mice and men: The relevance of transgenic mice Abeta immunizations to Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2002;4(5):431-4.
-
2002: Opazo Carlos; Huang Xudong; Cherny Robert A; Moir Robert D; Roher Alex E; White Anthony R; Cappai Roberto; Masters Colin L; Tanzi Rudolph E; Inestrosa Nibaldo C; Bush Ashley I
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).
The Journal of biological chemistry 2002;277(43):40302-8.
-
2002: Roher Alex E; Weiss Nicole; Kokjohn Tyler A; Kuo Yu-Min; Kalback Walter; Anthony Jacqueline; Watson Desiree; Luehrs Dean C; Sue Lucia; Walker Douglas; Emmerling Mark; Goux Warren; Beach Thomas
Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease.
Biochemistry 2002;41(37):11080-90.
-
2002: Walker Lary C; Callahan Michael J; Bian Feng; Durham Robert A; Roher Alex E; Lipinski William J
Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice.
Peptides 2002;23(7):1241-7.
-
2002: Dudkin K N; Chueva I V; Makarov F N; Beach T G; Roher A
Impaired processes of working memory in the monkey model of Alzheimer's disease.
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections / translated from Russian 2002;383():106-8.
-
2002: Kalback Walter; Watson M Desiree; Kokjohn Tyler A; Kuo Yu-Min; Weiss Nicole; Luehrs Dean C; Lopez John; Brune Daniel; Sisodia Sangram S; Staufenbiel Matthias; Emmerling Mark; Roher Alex E
APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.
Biochemistry 2002;41(3):922-8.
-
2001: Kuo Y M; Beach T G; Sue L I; Scott S; Layne K J; Kokjohn T A; Kalback W M; Luehrs D C; Vishnivetskaya T A; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller R O; Roher A E
The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
Molecular medicine (Cambridge, Mass.) 2001;7(9):609-18.
-
2001: Beach T G; Kuo Y M; Schwab C; Walker D G; Roher A E
Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine.
Neuroscience letters 2001;310(1):21-4.
-
2001: Shen Y; Lue L; Yang L; Roher A; Kuo Y; Strohmeyer R; Goux W J; Lee V; Johnson G V; Webster S D; Cooper N R; Bradt B; Rogers J
Complement activation by neurofibrillary tangles in Alzheimer's disease.
Neuroscience letters 2001;305(3):165-8.
-
2001: Kuo Y M; Kokjohn T A; Beach T G; Sue L I; Brune D; Lopez J C; Kalback W M; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Roher A E
Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains.
The Journal of biological chemistry 2001;276(16):12991-8.
-
2000: Munson G W; Roher A E; Kuo Y M; Gilligan S M; Reardon C A; Getz G S; LaDu M J
SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides.
Biochemistry 2000;39(51):16119-24.
-
2000: Yan S D; Roher A; Chaney M; Zlokovic B; Schmidt A M; Stern D
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.
Biochimica et biophysica acta 2000;1502(1):145-57.
-
2000: Roher A E; Baudry J; Chaney M O; Kuo Y M; Stine W B; Emmerling M R
Oligomerizaiton and fibril asssembly of the amyloid-beta protein.
Biochimica et biophysica acta 2000;1502(1):31-43.
-
2000: Atwood C S; Huang X; Khatri A; Scarpa R C; Kim Y S; Moir R D; Tanzi R E; Roher A E; Bush A I
Copper catalyzed oxidation of Alzheimer Abeta.
Cellular and molecular biology (Noisy-le-Grand, France) 2000;46(4):777-83.
-
2000: Yan S D; Zhu H; Zhu A; Golabek A; Du H; Roher A; Yu J; Soto C; Schmidt A M; Stern D; Kindy M
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.
Nature medicine 2000;6(6):643-51.
-
2000: Kuo Y M; Crawford F; Mullan M; Kokjohn T A; Emmerling M R; Weller R O; Roher A E
Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease.
Molecular medicine (Cambridge, Mass.) 2000;6(5):430-9.
-
2000: Kane M D; Lipinski W J; Callahan M J; Bian F; Durham R A; Schwarz R D; Roher A E; Walker L C
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(10):3606-11.
-
2000: Roher A E; Kuo Y M; Potter P E; Emmerling M R; Durham R A; Walker D G; Sue L I; Honer W G; Beach T G
Cortical cholinergic denervation elicits vascular A beta deposition.
Annals of the New York Academy of Sciences 2000;903():366-73.
-
2000: Sparks D L; Kuo Y M; Roher A; Martin T; Lukas R J
Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations.
Annals of the New York Academy of Sciences 2000;903():335-44.
-
2000: Emmerling M R; Morganti-Kossmann M C; Kossmann T; Stahel P F; Watson M D; Evans L M; Mehta P D; Spiegel K; Kuo Y M; Roher A E; Raby C A
Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.
Annals of the New York Academy of Sciences 2000;903():118-22.
-
2000: Weller R O; Massey A; Kuo Y M; Roher A E
Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;903():110-7.
-
2000: Beach T G; Kuo Y M; Spiegel K; Emmerling M R; Sue L I; Kokjohn K; Roher A E
The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease.
Journal of neuropathology and experimental neurology 2000;59(4):308-13.
-
2000: Beach T G; Potter P E; Kuo Y M; Emmerling M R; Durham R A; Webster S D; Walker D G; Sue L I; Scott S; Layne K J; Roher A E
Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition.
Neuroscience letters 2000;283(1):9-12.
-
2000: Kuo Y M; Kokjohn T A; Watson M D; Woods A S; Cotter R J; Sue L I; Kalback W M; Emmerling M R; Beach T G; Roher A E
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.
The American journal of pathology 2000;156(3):797-805.
-
2000: Kuo Y M; Kokjohn T A; Kalback W; Luehrs D; Galasko D R; Chevallier N; Koo E H; Emmerling M R; Roher A E
Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma.
Biochemical and biophysical research communications 2000;268(3):750-6.
-
1999: Yan S D; Roher A; Schmidt A M; Stern D M
Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.
The American journal of pathology 1999;155(5):1403-11.
-
1999: Lue L F; Kuo Y M; Roher A E; Brachova L; Shen Y; Sue L; Beach T; Kurth J H; Rydel R E; Rogers J
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
The American journal of pathology 1999;155(3):853-62.
-
1999: Roher A E; Kuo Y M; Kokjohn K M; Emmerling M R; Gracon S
Amyloid and lipids in the pathology of Alzheimer disease.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 1999;6(2):136-45.
-
1999: Kuo Y M; Emmerling M R; Lampert H C; Hempelman S R; Kokjohn T A; Woods A S; Cotter R J; Roher A E
High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.
Biochemical and biophysical research communications 1999;257(3):787-91.
-
1999: Yan S D; Shi Y; Zhu A; Fu J; Zhu H; Zhu Y; Gibson L; Stern E; Collison K; Al-Mohanna F; Ogawa S; Roher A; Clarke S G; Stern D M
Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity.
The Journal of biological chemistry 1999;274(4):2145-56.
-
1999: Lowenson J D; Clarke S; Roher A E
Chemical modifications of deposited amyloid-beta peptides.
Methods in enzymology 1999;309():89-105.
-
1999: Roher A E; Kuo Y M
Isolation of amyloid deposits from brain.
Methods in enzymology 1999;309():58-67.
-
1998: Raby C A; Morganti-Kossmann M C; Kossmann T; Stahel P F; Watson M D; Evans L M; Mehta P D; Spiegel K; Kuo Y M; Roher A E; Emmerling M R
Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid.
Journal of neurochemistry 1998;71(6):2505-9.
-
1998: Kuo Y M; Emmerling M R; Bisgaier C L; Essenburg A D; Lampert H C; Drumm D; Roher A E
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.
Biochemical and biophysical research communications 1998;252(3):711-5.
-
1998: Giulian D; Haverkamp L J; Yu J; Karshin W; Tom D; Li J; Kazanskaia A; Kirkpatrick J; Roher A E
The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.
The Journal of biological chemistry 1998;273(45):29719-26.
-
1998: Chaney M O; Webster S D; Kuo Y M; Roher A E
Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease.
Protein engineering 1998;11(9):761-7.
-
1998: Weller R O; Massey A; Newman T A; Hutchings M; Kuo Y M; Roher A E
Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.
The American journal of pathology 1998;153(3):725-33.
-
1998: Fiala M; Zhang L; Gan X; Sherry B; Taub D; Graves M C; Hama S; Way D; Weinand M; Witte M; Lorton D; Kuo Y M; Roher A E
Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.
Molecular medicine (Cambridge, Mass.) 1998;4(7):480-9.
-
1998: Yan S D; Stern D; Kane M D; Kuo Y M; Lampert H C; Roher A E
RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease.
Restorative neurology and neuroscience 1998;12(2-3):167-73.
-
1998: Kuo Y M; Webster S; Emmerling M R; De Lima N; Roher A E
Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease.
Biochimica et biophysica acta 1998;1406(3):291-8.
-
1997: Yan S D; Fu J; Soto C; Chen X; Zhu H; Al-Mohanna F; Collison K; Zhu A; Stern E; Saido T; Tohyama M; Ogawa S; Roher A; Stern D
An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.
Nature 1997;389(6652):689-95.
-
1997: Kuo Y M; Emmerling M R; Woods A S; Cotter R J; Roher A E
Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits.
Biochemical and biophysical research communications 1997;237(1):188-91.
-
1997: Du Yan S; Zhu H; Fu J; Yan S F; Roher A; Tourtellotte W W; Rajavashisth T; Chen X; Godman G C; Stern D; Schmidt A M
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):5296-301.
-
1996: Giulian D; Haverkamp L J; Yu J H; Karshin W; Tom D; Li J; Kirkpatrick J; Kuo L M; Roher A E
Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(19):6021-37.
-
1996: Yan S D; Chen X; Fu J; Chen M; Zhu H; Roher A; Slattery T; Zhao L; Nagashima M; Morser J; Migheli A; Nawroth P; Stern D; Schmidt A M
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
Nature 1996;382(6593):685-91.
-
1996: Roher A E; Chaney M O; Kuo Y M; Webster S D; Stine W B; Haverkamp L J; Woods A S; Cotter R J; Tuohy J M; Krafft G A; Bonnell B S; Emmerling M R
Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.
The Journal of biological chemistry 1996;271(34):20631-5.
-
1996: Bagchi M; Roher A E; Bannerjee A; Barrett R; Hazlett L D; Kasunic T; Maisel H
Identification of a ubiquitin-like protein in the mammalian vitreous humor.
Journal of cellular biochemistry 1996;61(1):26-30.
-
1996: Kuo Y M; Emmerling M R; Vigo-Pelfrey C; Kasunic T C; Kirkpatrick J B; Murdoch G H; Ball M J; Roher A E
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.
The Journal of biological chemistry 1996;271(8):4077-81.
-
1995: Grammas P; Moore P; Botchlet T; Hanson-Painton O; Cooper D R; Ball M J; Roher A
Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.
Neurobiology of aging 1995;16(4):563-9.
-
1995: Grammas P; Botchlet T; Fugate R; Ball M J; Roher A E
Alzheimer disease amyloid proteins inhibit brain endothelial cell proliferation in vitro.
Dementia (Basel, Switzerland) 1995;6(3):126-30.
-
1994: Roher A E; Kasunic T C; Woods A S; Cotter R J; Ball M J; Fridman R
Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.
Biochemical and biophysical research communications 1994;205(3):1755-61.
-
1994: Stojanovic A; Roher A E; Ball M J
Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brains.
Dementia (Basel, Switzerland) 1994;5(5):229-33.
-
1994: Gowing E; Roher A E; Woods A S; Cotter R J; Chaney M; Little S P; Ball M J
Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease.
The Journal of biological chemistry 1994;269(15):10987-90.
-
1994: Grammas P; Roher A E; Ball M J
Increased accumulation of cAMP in cerebral microvessels in Alzheimer's disease.
Neurobiology of aging 1994;15(1):113-6.
-
1993: Roher A E; Lowenson J D; Clarke S; Woods A S; Cotter R J; Gowing E; Ball M J
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(22):10836-40.
-
1993: Roher A E; Palmer K C; Yurewicz E C; Ball M J; Greenberg B D
Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue.
Journal of neurochemistry 1993;61(5):1916-26.
-
1993: Roher A E; Lowenson J D; Clarke S; Wolkow C; Wang R; Cotter R J; Reardon I M; Zürcher-Neely H A; Heinrikson R L; Ball M J
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
The Journal of biological chemistry 1993;268(5):3072-83.
-
1991: Roher A E; Palmer K C; Capodilupo J; Wakade A R; Ball M J
New biochemical insights to unravel the pathogenesis of Alzheimer's lesions.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(3 Suppl):408-10.
-
1991: Roher A E; Ball M J; Bhave S V; Wakade A R
Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.
Biochemical and biophysical research communications 1991;174(2):572-9.
-
1988: Roher A E; Palmer K C; Chau V; Ball M J
Isolation and chemical characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core protein.
The Journal of cell biology 1988;107(6 Pt 2):2703-16.
-
1988: Roher A; Gray E G; Paula-Barbosa M
Alzheimer's disease: coated vesicles, coated pits and the amyloid-related cell.
Proceedings of the Royal Society of London. Series B, Containing papers of a Biological character. Royal Society (Great Britain) 1988;232(1269):367-73.
-
1987: Palutke M; KuKuruga D; Wolfe D; Roher A
Flow cytometric purification of Alzheimer's disease amyloid plaque core protein using thioflavin T.
Cytometry 1987;8(5):494-9.
-
1987: Gray E G; Paula-Barbosa M; Roher A
Alzheimer's disease: paired helical filaments and cytomembranes.
Neuropathology and applied neurobiology 1987;13(2):91-110.
-
1986: Roher A; Wolfe D; Palutke M; KuKuruga D
Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(8):2662-6.
-
1986: Roher A; Lieska N; Spitz W
The amino acid sequence of human cardiac troponin-C.
Muscle & nerve 1986;9(1):73-7.
-
1985: Berk R S; Moon M; Higbee R; Cramer C; Roher A; Weis M; Hazlett L
Actinlike material in Pseudomonas aeruginosa.
Infection and immunity 1985;50(2):483-7.
Sign-in to see more